Neurokinin 3 Receptor Antagonist
DBCAT005910Therapeutic category
A DrugBank category of 2 drugs. 2 of them are approved.
What you can answer from here — as of March 09, 2024
Which targets do Neurokinin 3 Receptor Antagonist share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account